🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationFDA warning letters to compounding pharmacies — November 2025 Page 2

FDA warning letters to compounding pharmacies — November 2025

gary_naperville Thu, Dec 18, 2025 at 7:46 PM 36 replies 1,552 viewsPage 2 of 8
DoseLogDan
Member
201
567
Feb 2025
Montana
Dec 18, 2025 at 10:36 PM#6

This is incredibly helpful, thank you all. My doctor recommended a 503B facility called Empower. I looked them up and they're on the FDA registered list. Feeling much better about this now.

One more question — should I ask for the COA before or after filling the prescription? Is that a normal thing patients do? I don't want to come across as difficult. 😅

Last edited: Dec 18, 2025 at 11:36 PM
47 2newstart_MO, mia_MS2, LeilaHI and 44 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Dec 18, 2025 at 10:53 PM#7

Ask after you receive it — the COA is batch-specific so you need your lot number first. And don't worry about being "difficult." Any pharmacy worth using will happily provide a COA. If they refuse or act weird about it, that's a red flag the size of Texas. 🚩

3 13wei_SG, cory_ATX, lori_vegas
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Dec 18, 2025 at 11:10 PM#8

Pinning this thread as it's one of the best 503A vs 503B breakdowns we've had. Thanks to our pharmacy and compounding experts for the detailed input.

Quick mod note: please don't post direct links to purchase from specific pharmacies. Discussion and naming is fine, but we can't have the forum become a storefront. Thanks all. 👍

Last edited: Dec 19, 2025 at 5:10 AM
25 22BrianDallas92, labquiet_amy, emily_PDX and 22 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register